and recommendation
Biostage (BSTG)
Biostage is a biotechnology company developing bioengineered organ implants based on the Company's Cellframe™ technology which combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.
Cellspan implants are being developed to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of dramatically improving the treatment paradigm for patients.
Based on its pre-clinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- December 22, 2017 - 9:31am | Out and About, Research Notes
- December 18, 2017 - 9:33am | Out and About, Research Notes
- December 14, 2017 - 7:11pm | Out and About, Research Notes
- December 7, 2017 - 11:35am | Out and About, Research Notes
- December 6, 2017 - 2:13pm | Out and About, Research Notes
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- October 13, 2017 - 11:29am | Out and About
- October 6, 2017 - 8:06am | Out and About, Research Notes
- June 1, 2017 - 12:00am | Out and About, Research Notes
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- March 27, 2017 - 12:52pm | Out and About, Research Notes
- March 10, 2017 - 12:00am | Earnings, Earnings Q4
- February 10, 2017 - 4:16pm | Research Notes, Financings
- February 9, 2017 - 8:13pm | Research Notes, Financings
- February 9, 2017 - 1:13pm | Research Notes
- November 22, 2016 - 7:57am | Research Notes
- November 2, 2016 - 8:46pm | Earnings, Earnings Q3
- August 4, 2016 - 10:50pm | Earnings, Earnings Q2